Incidence of serious gastrointestinal events among tildrakizumab-treated patients with psoriasis: Letter to the Editor.
M GooderhamB E ElewskiD M PariserHoward SofenA M MendelsohnS J RozzoQ LiPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2019)